As Scientific Director at NewtonBio, Dr. Letha Chemmalil designs and develops engineered proteins for cell and gene therapy programs. Her extensive background includes leadership roles at Bristol-Myers Squibb and Amgen, focusing on protein characterization and analytical method development. She holds Masters degrees from both Tufts University and Worcester Polytechnic Institute.
She has invented and patented novel Process Analytical Technology (PAT) tools that enable near real-time quantitation of glycoproteins directly from bioreactors.
Read the full overview →
Experience
34 Years
Current Role
Scientific Director
Job Level
Mid-senior
Location
Greater Boston, United States
Personality Overview
How Dr. shows up
Relationship Oriented
Informal
Imaginative
They are not always early adopters but can be pursuaded by leveraging strong relationships. They are people oriented, friendly and like creating new connections. They excel at seeing the bigger picture, and the long-term impact of their decisions.
Priorities
Topics Dr. cares about
Engineered Proteins
Her current role focuses on designing serum-free engineered proteins using recombinant DNA or mRNA technologies for cell and gene therapy applications.
Process Analytical Technology
She has developed, published, and patented various PAT tools for the online, real-time monitoring of biopharmaceutical product and process attributes.
+5 more topicsLogin to view topics
Career
Work history
6-2024
Scientific Director
NewtonBio
1-2015 - 6-2024
Scientific Associate Director (current), Principal Scientist (2018-20) Senior Scientist-II (2015-18)
Influence (I) reflects the degree to which a person prefers to work by influencing or persuading others. Those scoring high tend to be people oriented, motivated by social recognition and building relationships.
More profiles
Discover additional public profiles from our index.